A CASE of coexisting stenosis of the mitral and pulmonic valves is described. Cardiac catheterization on a patient with stenosis of these 2 valves has not been reported to our knowledge. Gibson and Wood,' however, described 1 case with coexisting stenosis of these 2 valves and the tricuspid valve as well.
A modification of the formula for calculating pulmonic valvular resistance is described.
CASE REPORT AND METHODS
A 56-year-old Caucasian woman was well until the age of 25, when she had a full-term uncomplicated pregnancy. Several days following delivery, she first developed left precordial chest pain and was told by a physician that she had rheumatic heart disease with mitral stenosis. She had no history of rheumatic fever. The chest pain recurred intermittently for several days. She then became asymptomatic until the age of 32, when during the course of her second pregnancy, she first developed palpitation. The palpitation occurred infrequently at first, then with increasing frequency in the past 1 0 years, often 2 to 3 times per week with individual episodes lasting from several minutes to several days. On various occasions, they have been recorded by electrocardiogram as showing atrial tachycardia and atrial fibrillation. Quinidine was variably effective in terminating these paroxysmal attacks.
In April 1952, she had an initial episode of pulmonary edema. She was awakened from sleep with palpitation and dyspnea. Moist rales were present throughout both lung fields. She was treated with morphine sulfate and quinidine, and the pulmonary edema subsided as her heart rate slowed. An electrocardiogram taken after this episode showed first degree heart block (P-R interval of 0.22 second).
In April 1953, and again in March 1954, she had episodes of pulmonary edema arousing her from sleep and associated with marked tachycardia. As the cardiac rate returned to normal, the pulmonary edema subsided.
In arrhythmia was converted to a sinus rhythm with digitalis. Prior to this episode, she had not been treated with digitalis.
In July 1955, she had a paroxysm of atrial flutter that converted to atrial fibrillation while she was being digitalized, and subsequently to sinus rhythm with quinidine therapy. She has remained on digitalis since then, and has taken quinidine intermittently.
Aside from the periods of paroxysmal tachycardia, she has not had dyspnea on The relation of the systolic ejection phase to the cardliac cycle depends on the heart rate. WVith increases in heart rate, the systolic ejection phase shortens less, proportionately, than the diastolic phase, and therefore occupies a greater portion of each cardiac cycle. The effect of heart rate on the relative duration of the systolic ejection period is corrected in the revised formula.
Stenosis of the valve itself, as has been (lemonstrated with aortic stenosis, may also prolong the ejection phase of the cardiac cycle. The degree of stenosis may be an additional factor, therefore, in determining the relationship of the systolic ejection period to the total cardiac cycle. The effect of stenosis on the length of the systolic ejection phase is corrected in the revised formula.
In He found that pulmonary vascular resistance of more than 10 units would usually protect against the development of pulmonary vascular congestion and dyspnea. Normal pulmonary vascular resistance of 3.9 units or less did not afford this protection. In this case, although the patient had a normal pulmonary vascular resistance of 3.1 units, she did not develop dyspnea on effort, except on those occasions when the (lyspnea was brought on by paroxysmal tachycardia. In the presence of a normal vascular resistance, it is considered that the pulmonic stenosis protected her against pulmonary venous congestion and increasing pulmonary capillary pressure.
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